Shopping Cart
Remove All
Your shopping cart is currently empty
LSN3318839 (Alias: LSN-3318839, LSN 3318839)
Catalog No. T63166 Copy Product Info
Purity: 99.70%
😃Good
LSN3318839 is a potent and orally available glucagon-like peptide-1 receptor (GLP-1R) modulator.LSN3318839 enhances GLP-1R G-protein-coupled signaling and can be used to lower blood glucose.
LSN3318839
Copy Product Info😃Good
Catalog No. T63166
Alias LSN-3318839, LSN 3318839
LSN3318839 is a potent and orally available glucagon-like peptide-1 receptor (GLP-1R) modulator.LSN3318839 enhances GLP-1R G-protein-coupled signaling and can be used to lower blood glucose.
Cas No. 2764704-18-7
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $213 | In Stock | In Stock | |
| 5 mg | $538 | In Stock | In Stock | |
| 10 mg | $777 | In Stock | In Stock | |
| 25 mg | $1,180 | In Stock | In Stock | |
| 50 mg | $1,590 | In Stock | In Stock | |
| 100 mg | $2,170 | In Stock | In Stock |
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:99.70%
ee:97.96%
Appearance:Solid
Color:Yellow
Contact us for more batch information
Product Introduction
LSN3318839 AI Summary
LSN3318839 exhibits various bioactivities and pharmacokinetic properties. It functions as a positive allosteric modulator of the human GLP-1R, significantly increasing GLP-1(9-36) induced cAMP accumulation. Additionally, it acts as an agonist, with low EC50 values, for the GLP-1R by potentiating GLP-1(7-36) induced cAMP accumulation. It also shows partial agonist activity, moderately potentiating GLP-1(9-36) induced cAMP accumulation. This compound demonstrates anti-hyperglycemic activity in overnight-fasted GIPR KO C57BL/6 mice, effectively reducing blood glucose AUC at various doses and when used in combination with sitagliptin. It exhibits oral bioavailability and has been characterized by pharmacokinetic parameters such as clearance, half-life, volume of distribution, Cmax, and Tmax in different animal models..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | LSN3318839 is a potent and orally available glucagon-like peptide-1 receptor (GLP-1R) modulator.LSN3318839 enhances GLP-1R G-protein-coupled signaling and can be used to lower blood glucose. |
| Synonyms | LSN-3318839, LSN 3318839 |
| Molecular Weight | 480.39 |
| Formula | C26H23Cl2N3O2 |
| Cas No. | 2764704-18-7 |
| Smiles | [C@H](C)(N1C=2C(N=C1)=CN=C(C2)C3=C([C@H](C(O)=O)C)C=CC=C3)C4=C(Cl)C(=CC=C4Cl)C5CC5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 255 mg/mL (530.82 mM), Sonication is recommended.  | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy LSN3318839 | purchase LSN3318839 | LSN3318839 cost | order LSN3318839 | LSN3318839 chemical structure | LSN3318839 formula | LSN3318839 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.